Clinical Trial Update: A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C) [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for Brenipatide (LY3537031) in irritable bowel syndrome with constipation (IBS-C). The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Irritable Bowel Syndrome

Drugs mentioned

• Brenipatide

Snippet

Sponsor: Eli Lilly and Company | Conditions: Irritable Bowel Syndrome, Constipation | Phase 2 | Status: NOT_YET_RECRUITING